Skip to content
Drug and Device World
Home
News
Pharma News
Medical Device News
Obesity News
Sustainability
Latest in Sustainability
Sustainability News
Company Progress Report and Analysis
Expert Interviews
AI & Tech
Latest in AI and Technology
AI and Technology News
Expert Interviews
Features
Latest Features
In Conversation With
Exclusive Analysis
Wellness & Lifestyle
Members Only
Become A Member
Login
Manage Membership
FAQs
Contact Us
About the Author
Contact Us
Advertise
Search
Obesity
MyPhenome test predicts weight regain after bariatric surgery
May 29, 2025
Septerna’s stock climbs after Novo Nordisk inks $2.2 billion deal for obesity drugs
May 14, 2025
How employers can transform obesity care
May 9, 2025
seca debuts body composition tech for primary care
May 2, 2025
Phenomix trials MyPhenome test to predict response to semaglutide
April 9, 2025
Roche expands obesity pipeline, signs $5.3 billion deal for Zealand’s amylin analog
March 13, 2025
AbbVie signs $2.2 billion deal to license Gubra’s obesity drug
March 3, 2025
Lilly’s stock surges as diabetes products push 2024 revenue to $45 billion
February 6, 2025
Novo Nordisk’s shares climb as Wegovy demand and 2024 profits surge
February 6, 2025
Novo Nordisk boasts more weight loss with high-dose Wegovy
January 20, 2025
«
Previous Page
Home
Membership
Loading Comments...
Write a Comment...
Email
Name
Website
